H. Englert

2.0k total citations
41 papers, 1.3k citations indexed

About

H. Englert is a scholar working on Pathology and Forensic Medicine, Rheumatology and Dermatology. According to data from OpenAlex, H. Englert has authored 41 papers receiving a total of 1.3k indexed citations (citations by other indexed papers that have themselves been cited), including 24 papers in Pathology and Forensic Medicine, 15 papers in Rheumatology and 11 papers in Dermatology. Recurrent topics in H. Englert's work include Systemic Sclerosis and Related Diseases (24 papers), Dermatologic Treatments and Research (9 papers) and Systemic Lupus Erythematosus Research (9 papers). H. Englert is often cited by papers focused on Systemic Sclerosis and Related Diseases (24 papers), Dermatologic Treatments and Research (9 papers) and Systemic Lupus Erythematosus Research (9 papers). H. Englert collaborates with scholars based in Australia, United Kingdom and Cyprus. H. Englert's co-authors include A E Gharavi, Peter Brooks, J V Bertouch, E. Nigel Harris, Graham R.V. Hughes, S. Loizou, Stephen H. Morgan, Peter Youssef, G. Derue and Mark Walport and has published in prestigious journals such as The American Journal of Medicine, Annals of the Rheumatic Diseases and Emerging infectious diseases.

In The Last Decade

H. Englert

40 papers receiving 1.2k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
H. Englert Australia 20 631 583 260 238 231 41 1.3k
A J Silman United Kingdom 15 741 1.2× 416 0.7× 277 1.1× 219 0.9× 79 0.3× 22 1.6k
A. R. Ahmed United States 22 938 1.5× 1.3k 2.2× 367 1.4× 328 1.4× 86 0.4× 63 1.9k
Emilio B. González United States 19 448 0.7× 440 0.8× 211 0.8× 152 0.6× 108 0.5× 46 1.0k
Xavier Mariette France 13 671 1.1× 270 0.5× 554 2.1× 310 1.3× 286 1.2× 40 1.7k
F Fantini Italy 23 574 0.9× 448 0.8× 296 1.1× 767 3.2× 297 1.3× 69 1.6k
H M Moutsopoulos Greece 23 587 0.9× 266 0.5× 235 0.9× 106 0.4× 206 0.9× 43 1.3k
P. Nicaise‐Roland France 24 931 1.5× 166 0.3× 396 1.5× 262 1.1× 152 0.7× 56 1.5k
M. N. Manoussakis Greece 17 620 1.0× 227 0.4× 314 1.2× 132 0.6× 106 0.5× 22 1.1k
Alessandra Vacca Italy 22 512 0.8× 748 1.3× 370 1.4× 228 1.0× 63 0.3× 58 1.5k
Mo Yin Mok Hong Kong 26 981 1.6× 333 0.6× 931 3.6× 158 0.7× 241 1.0× 54 1.9k

Countries citing papers authored by H. Englert

Since Specialization
Citations

This map shows the geographic impact of H. Englert's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by H. Englert with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites H. Englert more than expected).

Fields of papers citing papers by H. Englert

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by H. Englert. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by H. Englert. The network helps show where H. Englert may publish in the future.

Co-authorship network of co-authors of H. Englert

This figure shows the co-authorship network connecting the top 25 collaborators of H. Englert. A scholar is included among the top collaborators of H. Englert based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with H. Englert. H. Englert is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
4.
Englert, H., P J Roberts-Thomson, Karen Byth, & Nicholas Manolios. (2008). Familial scleroderma: nature, nurture or both?. Internal Medicine Journal. 38(4). 235–242. 4 indexed citations
5.
Russo, Ricardo, et al.. (2006). Lack of increased expression of cell surface markers for circulating fibrocyte progenitors in limited scleroderma. Clinical Rheumatology. 26(7). 1136–1141. 10 indexed citations
6.
Englert, H., et al.. (2005). Systemic scleroderma: a spatiotemporal clustering. Internal Medicine Journal. 35(4). 228–233. 17 indexed citations
7.
Englert, H., Michael D. Thompson, Héctor Iván García García, et al.. (2004). Augmentation mammoplasty and ‘silicone‐osis’. Internal Medicine Journal. 34(12). 668–676. 9 indexed citations
8.
Englert, H., et al.. (2000). Male systemic sclerosis and occupational silica exposure—a population‐based study. Australian and New Zealand Journal of Medicine. 30(2). 215–220. 42 indexed citations
9.
Englert, H., Helen O’Connor, Kevin Davis, et al.. (1999). Familial risk estimation in systemic sclerosis. Australian and New Zealand Journal of Medicine. 29(1). 36–41. 53 indexed citations
10.
Stafford, L, et al.. (1998). Distribution of macrovascular disease in scleroderma. Annals of the Rheumatic Diseases. 57(8). 476–479. 57 indexed citations
11.
Englert, H., David L. Morris, & Lyn March. (1996). Scleroderma and silicone gel breast prostheses — the Sydney study revisited. Australian and New Zealand Journal of Medicine. 26(3). 349–355. 21 indexed citations
12.
Englert, H. & Peter Brooks. (1994). Scleroderma and augmentation mammoplasty ‐ a causal relationship?. Australian and New Zealand Journal of Medicine. 24(1). 74–80. 52 indexed citations
13.
Englert, H., Graydon Howe, Ronald Penny, & Peter Brooks. (1994). SCLERODERMA AND SILICONE BREAST IMPLANTS. Lara D. Veeken. 33(4). 397–399. 9 indexed citations
14.
Youssef, Peter, H. Englert, & J V Bertouch. (1993). Large vessel occlusive disease associated with CREST syndrome and scleroderma.. Annals of the Rheumatic Diseases. 52(6). 464–466. 41 indexed citations
15.
Englert, H., Paul Brennan, Don McNeil, Christopher J. Black, & A J Silman. (1992). Reproductive function prior to disease onset in women with scleroderma. Lara D. Veeken. 19. 1575–1579. 30 indexed citations
16.
Englert, H., S. Loizou, G. Derue, Mark Walport, & Graham R.V. Hughes. (1989). Clinical and immunologic features of livedo reticularis in lupus: A case-control study. The American Journal of Medicine. 87. 408–410. 5 indexed citations
17.
Englert, H., S. Loizou, G. Derue, Mark Walport, & Graham Hughes. (1989). Clinical and immunologic features of livedo reticularis in lupus: a case-control study. The American Journal of Medicine. 87(4). 408–410. 30 indexed citations
18.
Englert, H., S. Loizou, G R Hughes, V R Aber, & Mark Walport. (1986). Livedo reticularis and lupus erythematosus clinical and immunological associations. Lara D. Veeken. 1 indexed citations
19.
Harris, E. Nigel, A E Gharavi, U. M. Hegde, et al.. (1985). Anticardiolipin antibodies in autoimmune thrombocytopenic purpura. British Journal of Haematology. 59(2). 231–234. 164 indexed citations
20.
Englert, H., C H Hawkes, M L Boey, et al.. (1984). Degos' disease: association with anticardiolipin antibodies and the lupus anticoagulant.. BMJ. 289(6445). 576–576. 80 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026